Trademark: REDAXIN
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for REDAXIN
We do not have any records of a proof of use for REDAXIN at this moment.
Possible trademark infringements of REDAXIN
Basic Information about REDAXIN
- Serial Number
- 97488456
- Filing Date
- 05 Jul 2022
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of REDAXIN on the blockchain with WikiTrademarks.io.
- First use of REDAXIN anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 001
- US Codes
- 001; 005; 006; 010; 026; 046
- First use of REDAXIN anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 030
- US Codes
- 046
Who owns REDAXIN?
1. Redleaf Biologics, Inc. Lexington US
2. Redleaf Biologics, Inc. Lexington US
Correspondent
- Anthony F. Bonner, Jr.DINSMORE & SHOHL LLP
- 255 EAST FIFTH STREETSUITE 1900
- CINCINNATI,OH
- 45202
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io